Kent Pharmaceuticals Ltd: UK Public Sector Contracts Won & Awards

Companies House: Private Limited CompanyAshfordNationwide (UK)Main market: Pharmaceutical products

Official UK PPONPDQJ-6931-LMVQ

Procedures with an award3859 award records
i

How many tenders this supplier has won.

Tenders with at least one award to it. Award records are shown too, because one framework can carry many call-offs.

Public authorities9named on published awards
i

How many different public bodies have awarded to this supplier.

Buyers named on its awards, with duplicate names merged.

Attributable award value£7.7mnet · on 13 of 59 award records · single-supplier, no ceilings
i

How much this supplier has won, by published values.

Sum of award values where it was the only winner, VAT excluded, framework ceilings left out.

Not turnover. Not every award publishes a value.

Last 12 months11awards · 20 in the prior 24 months · last 27 Aug 2026
i

Awards to this supplier in the last 12 months.

Award records dated in the last 12 months, against the two years before.

Contracts ending ≤18 months14end date on 54 of 59 awards · 7 estimated
i

Contracts that finish in the next 18 months.

Contracts ending in that window by the published end date or, where only a duration is published, an estimate from signature plus duration (marked). Neither, not counted.

An end date does not confirm a new procurement.

Buyer regions4most often Scotland
i

In which regions this supplier wins work.

The region of each buyer it won from: the buyer’s office, placed by the official ONS postcode lookup. Each procedure counts once.

Where the buyer is based, not necessarily where the work was done; the tender page shows the published place of delivery.

Where they win
i

In which categories this supplier wins.

Distinct awards by the main category of the lot, or of the procedure when no lot is named. Repeat publications count once.

An award counts once in each class it covers; classes can overlap.

Active awards, plus pending awards whose standstill has ended or was not published.

58 awards (58 for a named lot, 100%, 0 for a whole procedure with no lot named) · top CPV classes, shares of all 58 awards. An award may cover more than one class.

3360 Pharmaceutical products58 awards · 100% · awards naming a lot
Attributable award value
i

How much this supplier has won, by published values.

Sum of award values where it was the only winner, VAT excluded, framework ceilings left out.

Not turnover. Not every award publishes a value.

£7.7mOn 13 of 59 award records; the five largest make 83%. Largest rows below.
Typical attributable award
i

What one of this supplier’s wins is usually worth.

Middle value of the same awards as the total above.

£432k middle valuerobust · n=13

Where their buyers are
i

In which regions this supplier wins work.

The region of each buyer it won from: the buyer’s office, placed by the official ONS postcode lookup. Each procedure counts once.

Where the buyer is based, not necessarily where the work was done; the tender page shows the published place of delivery.

ITL1 region of the buyer office · known for 38 of 38 awarded procedures · each procedure counts once

Scotland19 procedures · 50%
Wales (Cymru)14 procedures · 37%
Greater London4 procedures · 11%
Northern Ireland1 procedures · 3%

Bidding record
i

Competitions this supplier is known to have bid in.

Lots on Procurement Act 2023 award notices naming it as a bidder, split into won and lost. The lot is the contest: three lots of a ten-lot notice is three wins and seven losses.

Procurement Act 2023 award notices name every bidder · 4 notices name this supplier, covering 8 lots since 18 Dec 2025 · observed bids, not an estimate

Contract lots contested
i

Competitions this supplier is known to have bid in.

Lots on Procurement Act 2023 award notices naming it as a bidder, split into won and lost. The lot is the contest: three lots of a ten-lot notice is three wins and seven losses.

0 won · 0 lostFewer than three decided lots: no rate is claimed.
Framework / DPS places
i

Frameworks and DPS this supplier got onto.

Lots appointed out of lots applied for. Kept apart from contract wins because almost every compliant bidder gets a place.

8 of 8Lots on 4 notices: a place is won per lot.
Authorities bid for
i

How many public bodies this supplier has bid to.

Buyers on notices that name it as a bidder, win or lose.

1
NoticeAuthorityOutcomeBiddersPublished
NHS National Generic Pharmaceuticals - Wave 16aframework/DPSNHS Englandappointedall 3 lots bid for1259 Oct 2026
NHS National Generic Pharmaceuticals - Wave 15cframework/DPSNHS Englandappointedall 2 lots bid for11826 Feb 2026
NHS National Framework for Generics Housekeepingframework/DPSNHS Englandappointedall 2 lots bid for5322 Dec 2025
NHS National Proprietary Pharmaceuticals - Low Molecular Weight Heparins and Fondaparinux Productsframework/DPSNHS Englandappointed1118 Dec 2025

Bidder names come from Procurement Act 2023 award notices, which list every bidder (from 2025). Older notices name no bidders, so earlier contests do not appear here. Latest ten notices shown.

Who they sell to
i

Which public bodies award work to this supplier.

Authorities named on its published awards, ranked by distinct procedures, duplicate names merged.

Authorities named on this supplier’s published awards · ranked by distinct procedures · a framework or DPS adds one award record per appointed supplier

Authority type · official UK type when published, else name/id class, else not classified · by award records (a single panel can dominate)
i

What kinds of public bodies award work to this supplier.

Its award records by the authority’s published type, otherwise by its name. One framework can add many records.

  • NHS & health81%(47 awards)
    47 of 58 awards are NHS & health (81%).
  • Central government14%(8 awards)
    8 of 58 awards are Central government (14%).
  • Type not classified5%(3 awards)
    3 of 58 awards are Type not classified (5%).

Share = of the 38 procedures with an award naming this supplier. Last activity = award date, or notice publication when no award date was published.

Contracts ending
i

Contracts that finish in the next 18 months.

Contracts ending in that window by the published end date or, where only a duration is published, an estimate from signature plus duration (marked). Neither, not counted.

An end date does not confirm a new procurement.

54 of 59 awards carry an end date, 34 estimated from the duration · not a retender forecast

ContractEndsPublished value
Generic Drugs - Tablets & Capsules31 Jan 2027£586,036
Generic Anti-Infective Drugs31 Jan 2027£1,470,182
NHS National Framework for Generics Housekeeping Lot 1 - Oral Products31 May 2027£17,843,324
Desferoxamine Injections21 Jun 2027 estimated£263,956
All Other Presentations21 Jun 2027 estimated£28,861,104
Heparins & Anticoagulants30 Jun 2027£613,064
Generic Drugs – Injections/Infusions 230 Jun 2027£5,841,104
ENT, Ophthalmology & Skin Generic Medicines/Medical Devices7 Aug 2027 estimated£9,647,464
Artificial saliva products, Eye preparations & Skin creams7 Aug 2027 estimated£1,191,048
Lot 3 - CM/PHG/23/5699/03 Hospital only (housekeeping) products30 Sept 2027£37,160,000

Soonest 10 of 14.

Recent awards

Latest 30 of 59 award records naming this supplier

Award / procedureAuthorityAwardedPublished value
Generic, Branded Generic & Proprietary Medicinal Products - Group 18Regional Business Services Organisation Procurement and Logistics ServiceNot published£172,685 †
dynamic market estimate · not attributable revenue
Generic, Branded Generic & Proprietary Medicinal Products - Group 18Regional Business Services Organisation Procurement and Logistics ServiceNot published£30,167 †
dynamic market estimate · not attributable revenue
NP36126 Antibiotic & Genito Urinary MedicinesThe Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)Not published£36,398,668 †
framework ceiling · 1 of 38 appointed suppliers
Lot 21 - All other Analgesics and Anaesthetic Generic MedicinesThe Common Services Agency (more commonly known as NHS National Services Scotland) ("the Authority")Not published£15,957,588 †
framework ceiling · 1 of 37 appointed suppliers
Carbamazepine, lamotrigine, levodopa / carbidopa / entacapone, methylphenidate, phenytoin sodium, sodium valproate, and valproic acidThe Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)Not published£281,820 †
framework ceiling · 1 of 17 appointed suppliers
All other psychiatry and neurology medicinesThe Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)Not published£6,750,119 †
framework ceiling · 1 of 33 appointed suppliers
Generic Drugs - Topicals/MiscellaneousVelindre NHS Trust, NHS Wales Shared Services Partnership - Procurement Services (on behalf of All Wales LHB's and Trusts)Not published£11,814 †
from the contract notice
Aseptics Medicines (Including Cytotoxics)Velindre NHS Trust, NHS Wales Shared Services Partnership - Procurement Services (on behalf of All Wales LHB's and Trusts)Not published£431,864 †
from the contract notice
Proprietary DrugseTenderwalesNot published£60,800 †
from the contract notice
Desferoxamine InjectionsThe Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)Not published£263,956 †
framework ceiling · not attributable revenue
About this data
  • Source. Official UK public procurement notices (Find a Tender), reused under the Open Government Licence v3.0. New notices arrive through the day; the figures are rebuilt nightly.
  • One profile per supplier. Built from award and contract notices that name this supplier; different spellings and registration numbers of the same company are merged into this profile.
  • Values are published values. The table mirrors what the notice published: framework ceilings and joint awards are labelled and never counted as this supplier's money, and † marks a value taken from the contract notice when the award published none. Only awards made to this supplier alone count towards its value, excluding VAT. It is not turnover.
  • Regions on this page are where the work is delivered, not the supplier’s registered address.
  • Contract end dates. Published on 20 of 59 awards, estimated from the published duration on 34 more (marked “estimated”); those feed “Contracts ending”.
  • Every figure shows what it rests on. Not every notice publishes a bid count, a value or a delivery region, so each figure carries the number of records behind it, and one built on few records is marked as such. The on a figure explains it; the counting rules are in the methodology. Spotted something wrong? Tell us.